Tech Company Financing Transactions
Cortexyme Funding Round
Dolby Family Ventures and private investors participated in a $1 million Seed funding round for Cortexyme. The round was announced on 10/6/2014.
Transaction Overview
Company Name
Announced On
10/6/2014
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Seed
Investors
Dolby Family Ventures (David Dolby)
Proceeds Purpose
Cortexyme, which is developing novel therapeutics and diagnostics for Alzheimer's disease and other neurodegenerative disorders, received a $500,000 investment from Dolby Family Ventures as part of $1 million in seed financing to fund their preclinical research.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
269 East Grand Ave.
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Cortexyme (Nasdaq: CRTX) is developing treatments for Alzheimer's and other degenerative disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Casey Lynch
Chief Scientific Officer
Stephen Dominy
Executive Vice President
Leslie Holsinger
VP - Operations
Kristen Gafric
Browse more venture capital transactions:
Prev: 10/6/2014: LabStyle Innovations venture capital transaction
Next: 10/6/2014: Miramar Labs venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs